1. Contributions of chronic tobacco smoking to HIV-associated brain atrophy and cognitive deficits
- Author
-
Thomas Ernst, Hua-Jun Liang, Linda Chang, and Eric Cunningham
- Subjects
medicine.medical_specialty ,Immunology ,HIV Infections ,Article ,White matter ,Cognition ,Atrophy ,Central Nervous System Diseases ,Internal medicine ,Basal ganglia ,Tobacco Smoking ,medicine ,Humans ,Immunology and Allergy ,Effects of sleep deprivation on cognitive performance ,Working memory ,business.industry ,Brain ,Neurodegenerative Diseases ,medicine.disease ,Magnetic Resonance Imaging ,Subcortical gray matter ,Infectious Diseases ,medicine.anatomical_structure ,business ,Neurocognitive - Abstract
OBJECTIVES Tobacco smoking is linked to cognitive deficits and greater white matter (WM) abnormalities in people with HIV disease (PWH). Whether tobacco smoking additionally contributes to brain atrophy in PWH is unknown and was evaluated in this study. DESIGN We used a 2 × 2 design that included 83 PWH (43 nonsmokers, 40 smokers) and 171 HIV-seronegative (SN, 106 nonsmokers, 65 smokers) participants and assessed their brain structure and cognitive function. METHODS Selected subcortical volumes, voxel-wise cortical volumes and thickness, and total WM volume were analyzed using FreeSurfer. Independent and interactive effects of HIV and smoking were evaluated with two-way analysis of covariance on cognitive domain Z-scores and morphometric measures on T1-weighted MRI. RESULTS Regardless of smoking status, relative to SN, PWH had smaller brain volumes [basal ganglia, thalami, hippocampi, subcortical gray matter (GM) and cerebral WM volumes (p = 0.002-0.042)], steeper age-related declines in the right superior-parietal (interaction-p
- Published
- 2021
- Full Text
- View/download PDF